CI vs IMNN · P/E 2.4, rev $274.90B vs rev $500.0K
Cigna Corp (CI) versus Imunon Inc (IMNN) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Imunon Inc (IMNN) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IMNN currently screens at market cap $9.2M.
Not investment advice. Open the CI and IMNN stock pages for the full models.
Not investment advice.